hela human cervical cancer Search Results


90
National Centre for Cell Science human cervical adenocarcinoma cell line (hela)
Human Cervical Adenocarcinoma Cell Line (Hela), supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical adenocarcinoma cell line (hela)/product/National Centre for Cell Science
Average 90 stars, based on 1 article reviews
human cervical adenocarcinoma cell line (hela) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
BioVector NTCC human cervical cancer hela cell line
Human Cervical Cancer Hela Cell Line, supplied by BioVector NTCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical cancer hela cell line/product/BioVector NTCC
Average 90 stars, based on 1 article reviews
human cervical cancer hela cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
DS Pharma Biomedical human cervical cancer cell line hela
Human Cervical Cancer Cell Line Hela, supplied by DS Pharma Biomedical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical cancer cell line hela/product/DS Pharma Biomedical
Average 90 stars, based on 1 article reviews
human cervical cancer cell line hela - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Korean Cell Line Bank human epithelioid cervical adenocarcinoma (hela) cells
E2F8 expression in cervical cancer cell lines and correlation with suppressed cell proliferation. (A, B) The expression levels of E2F8 RNA and protein were significantly higher in some cervical cancer cell lines (CaSki, <t>HeLa,</t> and ME180) compared to that in normal control cells. (C) Using siE2F8, E2F8 knockdown was performed in E2F8-elevated HeLa cell lines. (D) The proliferation of HeLa cells transfected with siE2F8 and negative control siNC was determined using the CCK-8 assay. (E) Using shE2F8, E2F8 knockdown was performed in E2F8-elevated ME180 cell lines. (F) The proliferation of ME180 cells transfected with shE2F8 and negative scrambled control was determined using the CCK-8 assay. Each assay was performed in triplicate. Data are means ± standard deviation. ** P <0.01, ***P<0.001 vs siNC and scrambled control.
Human Epithelioid Cervical Adenocarcinoma (Hela) Cells, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human epithelioid cervical adenocarcinoma (hela) cells/product/Korean Cell Line Bank
Average 90 stars, based on 1 article reviews
human epithelioid cervical adenocarcinoma (hela) cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Pasteur Institute human cervical cancer (hela) cell line
E2F8 expression in cervical cancer cell lines and correlation with suppressed cell proliferation. (A, B) The expression levels of E2F8 RNA and protein were significantly higher in some cervical cancer cell lines (CaSki, <t>HeLa,</t> and ME180) compared to that in normal control cells. (C) Using siE2F8, E2F8 knockdown was performed in E2F8-elevated HeLa cell lines. (D) The proliferation of HeLa cells transfected with siE2F8 and negative control siNC was determined using the CCK-8 assay. (E) Using shE2F8, E2F8 knockdown was performed in E2F8-elevated ME180 cell lines. (F) The proliferation of ME180 cells transfected with shE2F8 and negative scrambled control was determined using the CCK-8 assay. Each assay was performed in triplicate. Data are means ± standard deviation. ** P <0.01, ***P<0.001 vs siNC and scrambled control.
Human Cervical Cancer (Hela) Cell Line, supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical cancer (hela) cell line/product/Pasteur Institute
Average 90 stars, based on 1 article reviews
human cervical cancer (hela) cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Keygen Biotech human cervical carcinoma hela cell lines
E2F8 expression in cervical cancer cell lines and correlation with suppressed cell proliferation. (A, B) The expression levels of E2F8 RNA and protein were significantly higher in some cervical cancer cell lines (CaSki, <t>HeLa,</t> and ME180) compared to that in normal control cells. (C) Using siE2F8, E2F8 knockdown was performed in E2F8-elevated HeLa cell lines. (D) The proliferation of HeLa cells transfected with siE2F8 and negative control siNC was determined using the CCK-8 assay. (E) Using shE2F8, E2F8 knockdown was performed in E2F8-elevated ME180 cell lines. (F) The proliferation of ME180 cells transfected with shE2F8 and negative scrambled control was determined using the CCK-8 assay. Each assay was performed in triplicate. Data are means ± standard deviation. ** P <0.01, ***P<0.001 vs siNC and scrambled control.
Human Cervical Carcinoma Hela Cell Lines, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical carcinoma hela cell lines/product/Keygen Biotech
Average 90 stars, based on 1 article reviews
human cervical carcinoma hela cell lines - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
CEM Corporation human cervical cancer (hela) cells
Cytotoxicity screening tests (IC 50 values (μM), 72 h).
Human Cervical Cancer (Hela) Cells, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical cancer (hela) cells/product/CEM Corporation
Average 90 stars, based on 1 article reviews
human cervical cancer (hela) cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Doshisha Corporation hela (human cervical cancer) cells
Plots of expected enhancement rates in DNA dsb in <t>HeLa</t> cells (A) × (C) shown in Table vs enhancement rates in cytotoxicity against HeLa cells (B) for 1 P1–3 (red line) and 1M 1–3 (purple line). The slopes of the red and blue lines are 0.44 and 0.053, respectively.
Hela (Human Cervical Cancer) Cells, supplied by Doshisha Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hela (human cervical cancer) cells/product/Doshisha Corporation
Average 90 stars, based on 1 article reviews
hela (human cervical cancer) cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Nanjing KeyGen Biotech Co Ltd human cervical cancer cell lines siha, caski, hela, me180
Forced expression of TFF3 in cervical cancer cells modulates the expression of malignant progression-related gene markers. a Determination of endogenous expression of TFF3 protein by Western blot in the cervical cancer cells lines CaSki, SiHa, <t>Me180</t> and Hela and human non-tumor keratinocyte line HaCaT. b Semi-quantitative RT-PCR analysis was used to assess the mRNA levels of TFF3 in SiHa and Hela cells with either forced or depleted expression of TFF3 as described in “ ” section. c Western blot analysis was used to assess the protein levels of TFF3 in SiHa and Hela cells with either forced or depleted expression of TFF3. d , e Quantitative PCR analysis quantifying the change in expression of various genes associated with malignant progression in SiHa-TFF3/Hela cells. Change in gene expression is expressed as fold difference, respectively. Fold change values are representative of three independent experiments
Human Cervical Cancer Cell Lines Siha, Caski, Hela, Me180, supplied by Nanjing KeyGen Biotech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical cancer cell lines siha, caski, hela, me180/product/Nanjing KeyGen Biotech Co Ltd
Average 90 stars, based on 1 article reviews
human cervical cancer cell lines siha, caski, hela, me180 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
BioResource International Inc human cervical carcinoma hela cells
Forced expression of TFF3 in cervical cancer cells modulates the expression of malignant progression-related gene markers. a Determination of endogenous expression of TFF3 protein by Western blot in the cervical cancer cells lines CaSki, SiHa, <t>Me180</t> and Hela and human non-tumor keratinocyte line HaCaT. b Semi-quantitative RT-PCR analysis was used to assess the mRNA levels of TFF3 in SiHa and Hela cells with either forced or depleted expression of TFF3 as described in “ ” section. c Western blot analysis was used to assess the protein levels of TFF3 in SiHa and Hela cells with either forced or depleted expression of TFF3. d , e Quantitative PCR analysis quantifying the change in expression of various genes associated with malignant progression in SiHa-TFF3/Hela cells. Change in gene expression is expressed as fold difference, respectively. Fold change values are representative of three independent experiments
Human Cervical Carcinoma Hela Cells, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical carcinoma hela cells/product/BioResource International Inc
Average 90 stars, based on 1 article reviews
human cervical carcinoma hela cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
AtaGenix Inc human cervical cancer hela
Forced expression of TFF3 in cervical cancer cells modulates the expression of malignant progression-related gene markers. a Determination of endogenous expression of TFF3 protein by Western blot in the cervical cancer cells lines CaSki, SiHa, <t>Me180</t> and Hela and human non-tumor keratinocyte line HaCaT. b Semi-quantitative RT-PCR analysis was used to assess the mRNA levels of TFF3 in SiHa and Hela cells with either forced or depleted expression of TFF3 as described in “ ” section. c Western blot analysis was used to assess the protein levels of TFF3 in SiHa and Hela cells with either forced or depleted expression of TFF3. d , e Quantitative PCR analysis quantifying the change in expression of various genes associated with malignant progression in SiHa-TFF3/Hela cells. Change in gene expression is expressed as fold difference, respectively. Fold change values are representative of three independent experiments
Human Cervical Cancer Hela, supplied by AtaGenix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical cancer hela/product/AtaGenix Inc
Average 90 stars, based on 1 article reviews
human cervical cancer hela - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Promega ready-to-use nuclear protein extracts of human cervical cancer cell line hela
Forced expression of TFF3 in cervical cancer cells modulates the expression of malignant progression-related gene markers. a Determination of endogenous expression of TFF3 protein by Western blot in the cervical cancer cells lines CaSki, SiHa, <t>Me180</t> and Hela and human non-tumor keratinocyte line HaCaT. b Semi-quantitative RT-PCR analysis was used to assess the mRNA levels of TFF3 in SiHa and Hela cells with either forced or depleted expression of TFF3 as described in “ ” section. c Western blot analysis was used to assess the protein levels of TFF3 in SiHa and Hela cells with either forced or depleted expression of TFF3. d , e Quantitative PCR analysis quantifying the change in expression of various genes associated with malignant progression in SiHa-TFF3/Hela cells. Change in gene expression is expressed as fold difference, respectively. Fold change values are representative of three independent experiments
Ready To Use Nuclear Protein Extracts Of Human Cervical Cancer Cell Line Hela, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ready-to-use nuclear protein extracts of human cervical cancer cell line hela/product/Promega
Average 90 stars, based on 1 article reviews
ready-to-use nuclear protein extracts of human cervical cancer cell line hela - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


E2F8 expression in cervical cancer cell lines and correlation with suppressed cell proliferation. (A, B) The expression levels of E2F8 RNA and protein were significantly higher in some cervical cancer cell lines (CaSki, HeLa, and ME180) compared to that in normal control cells. (C) Using siE2F8, E2F8 knockdown was performed in E2F8-elevated HeLa cell lines. (D) The proliferation of HeLa cells transfected with siE2F8 and negative control siNC was determined using the CCK-8 assay. (E) Using shE2F8, E2F8 knockdown was performed in E2F8-elevated ME180 cell lines. (F) The proliferation of ME180 cells transfected with shE2F8 and negative scrambled control was determined using the CCK-8 assay. Each assay was performed in triplicate. Data are means ± standard deviation. ** P <0.01, ***P<0.001 vs siNC and scrambled control.

Journal: International Journal of Biological Sciences

Article Title: E2F8 regulates the proliferation and invasion through epithelial-mesenchymal transition in cervical cancer

doi: 10.7150/ijbs.37686

Figure Lengend Snippet: E2F8 expression in cervical cancer cell lines and correlation with suppressed cell proliferation. (A, B) The expression levels of E2F8 RNA and protein were significantly higher in some cervical cancer cell lines (CaSki, HeLa, and ME180) compared to that in normal control cells. (C) Using siE2F8, E2F8 knockdown was performed in E2F8-elevated HeLa cell lines. (D) The proliferation of HeLa cells transfected with siE2F8 and negative control siNC was determined using the CCK-8 assay. (E) Using shE2F8, E2F8 knockdown was performed in E2F8-elevated ME180 cell lines. (F) The proliferation of ME180 cells transfected with shE2F8 and negative scrambled control was determined using the CCK-8 assay. Each assay was performed in triplicate. Data are means ± standard deviation. ** P <0.01, ***P<0.001 vs siNC and scrambled control.

Article Snippet: Human epithelioid cervical adenocarcinoma (HeLa) cells were obtained from the Korean Cell Line Bank (Seoul, Korea).

Techniques: Expressing, Control, Knockdown, Transfection, Negative Control, CCK-8 Assay, Standard Deviation

E2F8 promotes cell migration and invasion. (A, C) Wound healing assay observed under the optical microscope was used to determine cell migration using si and shE2F8. E2F8 knockdown was performed in E2F8-high HeLa and ME180 cell lines. (B, D) Cell invasion was observed under the optical microscope. Matrigel invasion assays were used to determine invasion after 48 h in HeLa and ME180 cells. Each assay was performed in triplicate. Data represent means ± standard deviation. ** P <0.01, *** P <0.001 vs. siNC and scrambled control.

Journal: International Journal of Biological Sciences

Article Title: E2F8 regulates the proliferation and invasion through epithelial-mesenchymal transition in cervical cancer

doi: 10.7150/ijbs.37686

Figure Lengend Snippet: E2F8 promotes cell migration and invasion. (A, C) Wound healing assay observed under the optical microscope was used to determine cell migration using si and shE2F8. E2F8 knockdown was performed in E2F8-high HeLa and ME180 cell lines. (B, D) Cell invasion was observed under the optical microscope. Matrigel invasion assays were used to determine invasion after 48 h in HeLa and ME180 cells. Each assay was performed in triplicate. Data represent means ± standard deviation. ** P <0.01, *** P <0.001 vs. siNC and scrambled control.

Article Snippet: Human epithelioid cervical adenocarcinoma (HeLa) cells were obtained from the Korean Cell Line Bank (Seoul, Korea).

Techniques: Migration, Wound Healing Assay, Microscopy, Knockdown, Standard Deviation, Control

Cytotoxicity screening tests (IC 50 values (μM), 72 h).

Journal: Molecules

Article Title: Synthesis and Pharmacological Effects of Diosgenin–Betulinic Acid Conjugates

doi: 10.3390/molecules25153546

Figure Lengend Snippet: Cytotoxicity screening tests (IC 50 values (μM), 72 h).

Article Snippet: The compounds 1 – 8 were subjected to the cytotoxicity screening tests on cells of human T-lymphoblastic leukemia (CEM), cells of human breast adenocarcinoma (MCF7), cells of human cervical cancer (HeLa), and human colon carcinoma (HCT 116 cancer cell lines), using normal human fibroblasts (BJ) as reference cell lines.

Techniques:

Plots of expected enhancement rates in DNA dsb in HeLa cells (A) × (C) shown in Table vs enhancement rates in cytotoxicity against HeLa cells (B) for 1 P1–3 (red line) and 1M 1–3 (purple line). The slopes of the red and blue lines are 0.44 and 0.053, respectively.

Journal: ACS Omega

Article Title: Roles of DNA Target in Cancer Cell-Selective Cytotoxicity by Dicopper Complexes with DNA Target/Ligand Conjugates

doi: 10.1021/acsomega.3c03387

Figure Lengend Snippet: Plots of expected enhancement rates in DNA dsb in HeLa cells (A) × (C) shown in Table vs enhancement rates in cytotoxicity against HeLa cells (B) for 1 P1–3 (red line) and 1M 1–3 (purple line). The slopes of the red and blue lines are 0.44 and 0.053, respectively.

Article Snippet: Prof. Kitagishi provided HeLa (human cervical cancer) cells used in this study (Doshisha University, Kyoto, Japan).

Techniques:

Confocal microscopic images of 1 P1–3 (200 μM) in HeLa cells in the dark on 1 h incubation. Bright-field images (A, E, I). Blue fluorescence indicates the fluorescence of 1 P1 (B), 1 P2 (F), and 1 P3 (J) (λ ex = 405 nm). Red fluorescence is mitochondrial staining by Mito Tracker Deep Red FM (50 nM) (Thermo Fisher) (C, G, K) (λ ex = 640 nm). (D, H, L) Overlay images of panels (A)–(C), (E)–(G), and (I)–(K), respectively. The scale bar is 20 μm.

Journal: ACS Omega

Article Title: Roles of DNA Target in Cancer Cell-Selective Cytotoxicity by Dicopper Complexes with DNA Target/Ligand Conjugates

doi: 10.1021/acsomega.3c03387

Figure Lengend Snippet: Confocal microscopic images of 1 P1–3 (200 μM) in HeLa cells in the dark on 1 h incubation. Bright-field images (A, E, I). Blue fluorescence indicates the fluorescence of 1 P1 (B), 1 P2 (F), and 1 P3 (J) (λ ex = 405 nm). Red fluorescence is mitochondrial staining by Mito Tracker Deep Red FM (50 nM) (Thermo Fisher) (C, G, K) (λ ex = 640 nm). (D, H, L) Overlay images of panels (A)–(C), (E)–(G), and (I)–(K), respectively. The scale bar is 20 μm.

Article Snippet: Prof. Kitagishi provided HeLa (human cervical cancer) cells used in this study (Doshisha University, Kyoto, Japan).

Techniques: Incubation, Fluorescence, Staining

In Vitro Cytotoxicity of 1 , 1 X , and Cisplatin against Various Cells in MTT Assay (48 h) (Mean ± SD)

Journal: ACS Omega

Article Title: Roles of DNA Target in Cancer Cell-Selective Cytotoxicity by Dicopper Complexes with DNA Target/Ligand Conjugates

doi: 10.1021/acsomega.3c03387

Figure Lengend Snippet: In Vitro Cytotoxicity of 1 , 1 X , and Cisplatin against Various Cells in MTT Assay (48 h) (Mean ± SD)

Article Snippet: Prof. Kitagishi provided HeLa (human cervical cancer) cells used in this study (Doshisha University, Kyoto, Japan).

Techniques: In Vitro, MTT Assay

Data for the Plot of Expected Enhancement Rates ( 1 X / 1 ) in DNA dsb in  HeLa  Cells (A) × (C) vs Enhancement Rates ( 1 X / 1 ) in Cytotoxicity against  HeLa  Cells (B) <xref ref-type= a " width="100%" height="100%">

Journal: ACS Omega

Article Title: Roles of DNA Target in Cancer Cell-Selective Cytotoxicity by Dicopper Complexes with DNA Target/Ligand Conjugates

doi: 10.1021/acsomega.3c03387

Figure Lengend Snippet: Data for the Plot of Expected Enhancement Rates ( 1 X / 1 ) in DNA dsb in HeLa Cells (A) × (C) vs Enhancement Rates ( 1 X / 1 ) in Cytotoxicity against HeLa Cells (B) a

Article Snippet: Prof. Kitagishi provided HeLa (human cervical cancer) cells used in this study (Doshisha University, Kyoto, Japan).

Techniques:

Forced expression of TFF3 in cervical cancer cells modulates the expression of malignant progression-related gene markers. a Determination of endogenous expression of TFF3 protein by Western blot in the cervical cancer cells lines CaSki, SiHa, Me180 and Hela and human non-tumor keratinocyte line HaCaT. b Semi-quantitative RT-PCR analysis was used to assess the mRNA levels of TFF3 in SiHa and Hela cells with either forced or depleted expression of TFF3 as described in “ ” section. c Western blot analysis was used to assess the protein levels of TFF3 in SiHa and Hela cells with either forced or depleted expression of TFF3. d , e Quantitative PCR analysis quantifying the change in expression of various genes associated with malignant progression in SiHa-TFF3/Hela cells. Change in gene expression is expressed as fold difference, respectively. Fold change values are representative of three independent experiments

Journal: Cancer Cell International

Article Title: Overexpression of trefoil factor 3 (TFF3) contributes to the malignant progression in cervical cancer cells

doi: 10.1186/s12935-016-0379-1

Figure Lengend Snippet: Forced expression of TFF3 in cervical cancer cells modulates the expression of malignant progression-related gene markers. a Determination of endogenous expression of TFF3 protein by Western blot in the cervical cancer cells lines CaSki, SiHa, Me180 and Hela and human non-tumor keratinocyte line HaCaT. b Semi-quantitative RT-PCR analysis was used to assess the mRNA levels of TFF3 in SiHa and Hela cells with either forced or depleted expression of TFF3 as described in “ ” section. c Western blot analysis was used to assess the protein levels of TFF3 in SiHa and Hela cells with either forced or depleted expression of TFF3. d , e Quantitative PCR analysis quantifying the change in expression of various genes associated with malignant progression in SiHa-TFF3/Hela cells. Change in gene expression is expressed as fold difference, respectively. Fold change values are representative of three independent experiments

Article Snippet: Human cervical cancer cell lines SiHa, CaSki, Hela, Me180 and human non-tumor keratinocyte line HaCaT were obtained from Nanjing KeyGen Biotech Co, Ltd (Nanjing,China).

Techniques: Expressing, Western Blot, Quantitative RT-PCR, Real-time Polymerase Chain Reaction, Gene Expression